| For: | Yan F, Xue XL, Guo Y, Zhang QR, You RR, Shang J, Wu XP, Geng JW, Gao XH, Ye Q, Liang J, Wang XY, Zeng JY, Chen J, Lin YC, Chen XY, Du Q, Yin WL, Liu L, Wang F, Xu BG, Zhang WH, Xiang HL. Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study. World J Gastroenterol 2026; 32(12): 116287 [DOI: 10.3748/wjg.v32.i12.116287] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i12/116287.htm |
| Number | Citing Articles |
| 1 |
Cheng-Yuan Tsai, Ching-Shan Huang. Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B. World Journal of Gastroenterology 2026; 32(37): 119736 doi: 10.3748/wjg.119736
|
| 2 |
Ling-Feng Zou, Shao-Ding Yu, Yan Luo, Cheng-Long Wang. Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration. World Journal of Gastroenterology 2026; 32(38): 119697 doi: 10.3748/wjg.119697
|